Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
30.0%
% of PJP's 30 holdings also in PPH
39.1%
% of PPH's 26 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 6.0% | 7.5% | 6.0% |
|
ELI LILLY & CO | 5.7% | 13.8% | 5.7% |
|
JOHNSON & JOHNSON | 5.3% | 7.4% | 5.3% |
|
MERCK & CO. INC. | 4.7% | 4.7% | 4.7% |
|
BRISTOL-MYERS SQUIBB CO | 5.2% | 4.6% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to PPH
|
ABBOTT LABORATORIES | 5.8% |
|
AMGEN INC | 5.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | 3.6% |
|
GILEAD SCIENCES INC | 3.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 2.9% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.9% |
|
BIOSANTE PHARMACEUTICALS INC | 2.8% |
|
TRAVERE THERAPEUTICS, INC. | 2.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 2.6% |
|
TARSUS PHARMACEUTICALS, INC. | 2.6% |
PJP Underweight Relative to PPH
|
ELI LILLY & CO | -8.0% |
 |
NOVO-NORDISK A/S-SPONS ADR | -6.2% |
 |
NOVARTIS AG-ADR | -5.5% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.5% |
 |
SANOFI-AVENTIS-ADR | -5.3% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -5.0% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.8% |
|
MCKESSON CORP | -4.8% |
|
CENCORA INC | -4.7% |
|
ZOETIS INC | -4.1% |